Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of lascufloxacin (KRP-AM1977X) in hepatic dysfunction
jRCT2080225073Phase 1Completed
- Sponsor
- Kyorin Pharmaceutical
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of lascufloxacin in hepatic disease (2 arms), sponsored by Kyorin Pharmaceutical. Primary endpoint: Pharmacokinetic parameters of lascufloxacin (AM-1977). Started Feb 2020; status: completed.
02
Drugs
lascufloxacin
03
Conditions
hepatic disease
Beyond the preview
Go deeper on jRCT2080225073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225073.